← Leaderboards
Greg Martin
Albany Molecular Research, Inc.
$1,915,086
Attributed
$1,915,086
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2019–20$2M$1.5M$1M$500K$0
'19
'20
Funding mix
By agency
NIH$1,915,086 · 1
By mechanism
N01$1,915,086 · 1
Top collaborators
No co-investigators on record.
Most similar at Albany Molecular Research, Inc.
Same institution · by research overlap
- Melissa Allard$16,991,646
- Gregory Martin$806,362
- Jianxie Chen$554,127
- Jian-Xie Chen$1,056,500
- , Josã-Luis Barredo$443,000
Others in their field
Other Emerging Leaders on “Toxin”
- Milan Tomic · Nanotherapeutics, Inc.$13,935,526
- Stephen Wilson · La Jolla Institute For Immunology$11,742,477
- Karen Marie Dobos · Colorado State University$8,392,076
- Leslie C. Sherwood · University Of Louisville$8,306,360
- Zhiyong Yang · Fzata, Inc.$8,266,129
- Jeongmin Song · Cornell University$7,814,606
Research focus
ToxinIn VivoLeadMicrobiologyPathogenPre-ClinicalProduct DevelopmentProgramsSafetyServicesSupport ContractsTherapeutic DevelopmentToxicologyChemistryCommunicable DiseasesDevelopment PlansDrug KineticsEvaluationInterventional Agent DevelopmentIn VitroAntiviral AgentsChemical SynthesisProcess OptimizationEnterovirus
Grant awards (3)
Task C10: Chemical Synthesis and Process Optimization of an anti-viral for enteroviruses and coronaviruses$844,080
N01 · FY2020 · AI · contact PI
Task C10: Chemical Synthesis and Process Optimization of an anti-viral for enteroviruses and coronaviruses$281,360
N01 · FY2020 · AI · contact PI
Task C06: Preparation of a non-GMP Antibiotic Candidate$789,646
N01 · FY2019 · AI · contact PI